Targeting lineage-specific transcription factors and cytokines of the th17/treg axis by novel 1,3,4-oxadiazole derivatives of pyrrolo[3,4-d]pyridazinone attenuates tnbs-induced experimental colitis

HIGHLIGHTS

• who: Marta Szandruk-Bender and colleagues from the Department of Pharmacology, Wroclaw Medical University, Mikulicza-Radeckiego, Wrocu0142aw, Poland have published the research work: Targeting Lineage-Specific Transcription Factors and Cytokines of the Th17/Treg Axis by Novel 1,3,4-Oxadiazole Derivatives of Pyrrolo[3,4-d]pyridazinone Attenuates TNBS-Induced Experimental Colitis, in the Journal: (JOURNAL) of 15/01/2020
• what: Thedistal difference inthe thecolon bodyofweight between days 15placed and 17onofanthe experiment was Then, the 8 cm of each rat was extracted, ice-cold plate, opened analyzed.
• how: It is worth emphasizing . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.